Richard Scolyer
Professor
Pathology
University of Sydney
Australia
Biography
Dr.Richard Scolyer is a Consultant Pathologist and Co-Director of Research, Melanoma Institute Australia
Research Interest
Pathology
Publications
-
Moller, I., Murali, R., Muller, H., Wiesner, T., Jackett, L., Scholz, S., Cosgarea, I., van de Nes, J., Sucker, A., Hillen, U., Scolyer, R., et al (2017). Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi. Modern Pathology, 30(3), 350-356.
-
Patrick, E., Schramm, S., Ormerod, J., Scolyer, R., Mann, G., Mueller, S., Yang, J. (2017). A multi-step classifier addressing cohort heterogeneity improves performance of prognostic biomarkers in three cancer types. Oncotarget, 8(2), 2807-2815
-
Lee, J., Vilain, R., Granter, S., Hu, N., Bresler, S., Xu, S., Frank, A., Mihm, M., Saw, R., Fletcher, C., Scolyer, R., et al (2017). 5-Hydroxymethylcytosine is a Nuclear Biomarker to Assess Biological Potential in Histologically Ambiguous Heavily Pigmented Melanocytic Neoplasms. Journal Of Cutaneous Pathology, 44(3), 249-
